Universal Vision Biotechnology Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 4,082.26 million compared to TWD 3,494.06 million a year ago. Net income was TWD 1,045.09 million compared to TWD 850.53 million a year ago.

Basic earnings per share from continuing operations was TWD 12.34 compared to TWD 10.04 a year ago. Diluted earnings per share from continuing operations was TWD 12.31 compared to TWD 10.02 a year ago.